Leslie Tari - 31 Mar 2022 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role: CHIEF SCIENTIFIC OFFICER
Signature: /s/ Leslie Tari
Issuer symbol: CDTX
Transactions as of: 31 Mar 2022
Net transactions value: $0
Form type: 4
Filing time: 04 Apr 2022, 17:07:29 UTC
Previous filing: 07 Jan 2022
Next filing: 13 Sep 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDTX	Common Stock	Award	$0	+52,500	+34%	$0.000000	207,900	31 Mar 2022	Direct	F1
holding	CDTX	Common Stock						13,298	31 Mar 2022	By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDTX	Employee Stock Option (right to buy)	Award	$0	+105,000		$0.000000	105,000	31 Mar 2022	Common Stock	105,000	$0.8300	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents time-based Restricted Stock Units (RSUs) granted on March 31, 2022. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2023, 2024, and 2025, subject to continuous service through each such vesting date.
F2	The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 31, 2022.